(Q46954782)

26 December 2017

title

Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice (English)

1 reference

26 December 2017

0 references

3

1 reference

26 December 2017

author name string

Ellen Aasum

1

1 reference

26 December 2017

Ahmed Murtaz Khalid

2

1 reference

26 December 2017

Ole-Jakob How

4

1 reference

26 December 2017

Rolf K Berge

5

1 reference

26 December 2017

Terje S Larsen

6

1 reference

26 December 2017

publication date

7 September 2007

1 reference

26 December 2017

Journal of Molecular and Cellular Cardiology

published in

1 reference

26 December 2017

volume

44

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

201-209

1 reference

26 December 2017

Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Changes in fatty acid transport and transporters are related to the severity of insulin deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia/reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Enhancement of long-chain acyl-CoA hydrolase activity in peroxisomes and mitochondria of rat liver by peroxisomal proliferators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 diabeticdb/dbmice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Fatty acid homeostasis in the normoxic and ischemic heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Estimation of peroxisomal beta-oxidation in rat heart by a direct assay of acyl-CoA oxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Cytochrome P450, peroxisome proliferation, and cytoplasmic fatty acid-binding protein content in liver, heart and kidney of the diabetic rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Stimulation of microperoxisomal beta-oxidation in rat heart by high-fat diets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Lipotoxic heart disease in obese rats: implications for human obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

The metabolic syndrome and the hepatic fatty acid drainage hypothesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Myocardial substrate metabolism in the normal and failing heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Chronic activation of PPARalpha is detrimental to cardiac recovery after ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Treatment of type 2 diabeticdb/dbmice with a novel PPARγ agonist improves cardiac metabolism but not contractile function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-alpha or -gamma agonists in a type 2 diabetic animal model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

The PPAR-alpha activator fenofibrate fails to provide myocardial protection in ischemia and reperfusion in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2007.08.020

10.1016/J.YJMCC.2007.08.020

7 January 2021

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

17931655

1 reference

26 December 2017